Literature DB >> 15220451

Parvovirus B19-induced apoptosis of hepatocytes.

Brian D Poole1, Yuory V Karetnyi, Stanley J Naides.   

Abstract

Parvovirus B19 (B19 virus) can persist in multiple tissues and has been implicated in a variety of diseases, including acute fulminant liver failure. The mechanism by which B19 virus induces liver failure remains unknown. Hepatocytes are nonpermissive for B19 virus replication. We previously reported that acute fulminant liver failure associated with B19 virus infection was characterized by hepatocellular dropout. We inoculated both primary hepatocytes and the hepatocellular carcinoma cell line Hep G2 with B19 virus and assayed for apoptosis by using annexin V staining. Reverse transcriptase PCR analysis and immunofluorescence demonstrated that B19 virus was able to infect the cells and produce its nonstructural protein but little or no structural capsid protein. Infection with B19 virus induced means of 28% of Hep G2 cells and 10% of primary hepatocytes to undergo apoptosis, which were four- and threefold increases, respectively, over background levels. Analysis of caspase involvement showed that B19 virus-inoculated cultures had a significant increase in the number of cells with active caspase 3. Inhibition studies demonstrated that caspases 3 and 9, but not caspase 8, are required for B19 virus-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15220451      PMCID: PMC434113          DOI: 10.1128/JVI.78.14.7775-7783.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  The cutaneous manifestations of human parvovirus B19 infection.

Authors:  C M Magro; M R Dawood; A N Crowson
Journal:  Hum Pathol       Date:  2000-04       Impact factor: 3.466

2.  Identification of a novel RNA splicing pattern as a basis of restricted cell tropism of erythrovirus B19.

Authors:  J Brunstein; M Söderlund-Venermo; K Hedman
Journal:  Virology       Date:  2000-09-01       Impact factor: 3.616

3.  Human parvovirus B19 infection in acute fulminant liver failure.

Authors:  Y V Karetnyi; P R Beck; R S Markin; A N Langnas; S J Naides
Journal:  Arch Virol       Date:  1999       Impact factor: 2.574

4.  Bone marrow failure in children with acute liver failure.

Authors:  J Tung; N Hadzic; M Layton; A J Baker; A Dhawan; M Rela; N D Heaton; G Mieli-Vergani
Journal:  J Pediatr Gastroenterol Nutr       Date:  2000-11       Impact factor: 2.839

5.  Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue.

Authors:  K Hokynar; J Brunstein; M Söderlund-Venermo; O Kiviluoto; E K Partio; Y Konttinen; K Hedman
Journal:  J Gen Virol       Date:  2000-04       Impact factor: 3.891

6.  Adeno-associated virus type 2 Rep78 induces apoptosis through caspase activation independently of p53.

Authors:  M Schmidt; S Afione; R M Kotin
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

7.  Recombinant parvovirus B19 empty capsids inhibit fetal hematopoietic colony formation in vitro.

Authors:  B Lindton; T Tolfvenstam; O Norbeck; L Markling; O Ringdén; M Westgren; K Broliden
Journal:  Fetal Diagn Ther       Date:  2001 Jan-Feb       Impact factor: 2.587

8.  Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors.

Authors:  M Moehler; B Blechacz; N Weiskopf; M Zeidler; W Stremmel; J Rommelaere; P R Galle; J J Cornelis
Journal:  Cancer Gene Ther       Date:  2001-03       Impact factor: 5.987

9.  Chronic parvovirus B-19 meningoencephalitis with additional detection of Epstein-Barr virus DNA in the cerebrospinal fluid of an immunocompetent patient.

Authors:  K Druschky; J Walloch; J Heckmann; B Schmidt; H Stefan; B Neundörfer
Journal:  J Neurovirol       Date:  2000-10       Impact factor: 2.643

10.  Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence.

Authors:  F Foto; K G Saag; L L Scharosch; E J Howard; S J Naides
Journal:  J Infect Dis       Date:  1993-03       Impact factor: 5.226

View more
  38 in total

1.  Acute fulminant hepatic failure associated with parvovirus B19 infection in an immunocompetent adult.

Authors:  Robert J Huang; Brandon C Varr; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2012-03-07       Impact factor: 3.199

2.  Chronic hepatitis caused by persistent parvovirus B19 infection.

Authors:  Trine H Mogensen; Jens Magnus B Jensen; Stephen Hamilton-Dutoit; Carsten S Larsen
Journal:  BMC Infect Dis       Date:  2010-08-20       Impact factor: 3.090

3.  Molecular characterization of human parvovirus B19 genotypes 2 and 3.

Authors:  Zhaojun Chen; Wuxiang Guan; Fang Cheng; Aaron Yun Chen; Jianming Qiu
Journal:  Virology       Date:  2009-09-15       Impact factor: 3.616

4.  Acute hepatitis as a manifestation of parvovirus B19 infection.

Authors:  Aleisha Hatakka; Julianne Klein; Runtao He; Jessica Piper; Edward Tam; Andrew Walkty
Journal:  J Clin Microbiol       Date:  2011-07-06       Impact factor: 5.948

5.  Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue.

Authors:  Päivi Norja; Kati Hokynar; Leena-Maija Aaltonen; Renwei Chen; Annamari Ranki; Esa K Partio; Olli Kiviluoto; Irja Davidkin; Tomi Leivo; Anna Maria Eis-Hübinger; Beate Schneider; Hans-Peter Fischer; René Tolba; Olli Vapalahti; Antti Vaheri; Maria Söderlund-Venermo; Klaus Hedman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

6.  Characterization of erythrovirus B19 genomes isolated in liver tissues from patients with fulminant hepatitis and biliary atresia who underwent liver transplantation.

Authors:  Kenji Abe; Tetsuya Kiuchi; Koichi Tanaka; Yoshihiro Edamoto; Naoto Aiba; Tetsutaro Sata
Journal:  Int J Med Sci       Date:  2007-04-05       Impact factor: 3.738

7.  Swine acute diarrhea syndrome coronavirus-induced apoptosis is caspase- and cyclophilin D- dependent.

Authors:  Jiyu Zhang; Yuru Han; Hongyan Shi; Jianfei Chen; Xin Zhang; Xiaobo Wang; Ling Zhou; Jianbo Liu; Jialin Zhang; Zhaoyang Ji; Zhaoyang Jing; Jingyun Ma; Da Shi; Li Feng
Journal:  Emerg Microbes Infect       Date:  2020-02-24       Impact factor: 7.163

8.  Parvovirus B19 genotype specific amino acid substitution in NS1 reduces the protein's cytotoxicity in culture.

Authors:  Violetta Kivovich; Leona Gilbert; Matti Vuento; Stanley J Naides
Journal:  Int J Med Sci       Date:  2010-05-25       Impact factor: 3.738

9.  Human parvovirus B19 nonstructural protein NS1 enhanced the expression of cleavage of 70 kDa U1-snRNP autoantigen.

Authors:  Bor-Show Tzang; Der-Yuan Chen; Chun-Chou Tsai; Szu-Yi Chiang; Tsung-Ming Lin; Tsai-Ching Hsu
Journal:  J Biomed Sci       Date:  2010-05-25       Impact factor: 8.410

10.  The determinants for the enzyme activity of human parvovirus B19 phospholipase A2 (PLA2) and its influence on cultured cells.

Authors:  Xuefeng Deng; Yanming Dong; Qianhui Yi; Yu Huang; Dan Zhao; Yongbo Yang; Peter Tijssen; Jianming Qiu; Kaiyu Liu; Yi Li
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.